SeaCrest Wealth Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,825
| Closed | -$266K | – | 1642 |
|
|
2022
Q2 | $266K | Sell |
1,825
-975
| -35% | -$142K | 0.03% | 508 |
|
|
2022
Q1 | $332K | Sell |
2,800
-50
| -2% | -$5.93K | 0.04% | 481 |
|
|
2021
Q4 | $393K | Buy |
2,850
+175
| +7% | +$24.1K | 0.04% | 428 |
|
|
2021
Q3 | $372K | Buy |
2,675
+300
| +13% | +$41.7K | 0.04% | 431 |
|
|
2021
Q2 | $231K | Buy |
+2,375
| New | +$231K | 0.03% | 593 |
|
|
2021
Q1 | – | Sell |
-2,650
| Closed | -$227K | – | 696 |
|
|
2020
Q4 | $227K | Buy |
+2,650
| New | +$227K | 0.03% | 527 |
|
|
2019
Q2 | – | Sell |
-2,165
| Closed | -$111K | – | 2228 |
|
|
2019
Q1 | $111K | Buy |
2,165
+15
| +0.7% | +$769 | 0.02% | 655 |
|
|
2018
Q4 | $80K | Hold |
2,150
| – | – | 0.02% | 742 |
|
|
2018
Q3 | $81K | Sell |
2,150
-200
| -9% | -$7.54K | 0.01% | 824 |
|
|
2018
Q2 | $93K | Buy |
2,350
+350
| +18% | +$13.9K | 0.02% | 746 |
|
|
2018
Q1 | $52K | Sell |
2,000
-350
| -15% | -$9.1K | 0.01% | 944 |
|
|
2017
Q4 | $63K | Buy |
+2,350
| New | +$63K | 0.01% | 877 |
|